Clicky

Shenzhen Kangtai Biological Products Co Ltd(300601)

Description: Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China. The company's products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined with live attenuated vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, and HIB conjugate vaccine. It has an agreement between YTB and Yong Tai Berhad in relation to the development and commercialization of Covid-19 inactivated vaccine in Malaysia. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.


Keywords: Medicine Vaccines Bacteria Rabies Tetanus Measles Pertussis Rubella Book:Medications Conjugate Vaccine Diphtheria Poliomyelitis

Home Page: www.biokangtai.com

Science and Technology Park
Shenzhen, 518057
China
Phone: 86 755 2698 8658


Officers

Name Title
Mr. Xiang Miao Pres & Non-Independent Director
Mr. Haifa Zheng Vice Chairman & VP
Mr. Jiankai Liu VP & Non-Independent Director
Ms. Jin Tao Board Sec.

Exchange: SHE

Country: CN

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 44.9756
Price-to-Book MRQ: 4.1905
Price-to-Sales TTM: 9.4952
IPO Date:
Fiscal Year End: December
Full Time Employees: 2445
Back to stocks